1
Nagashima Shinya, Nagata Hiroshi, Iwata Masahiro, Yokota Masaki, Moritomo Hiroyuki, Nakai Eiichi, Kuromitsu Sadao, Ohga Keiko, Takeuchi Makoto: (Ja) ジアミノピリミジンカルボキサミド誘導体, (En) Diaminopyrimidinecarboxa mide derivative. Yamanouchi Pharmaceutical, Nagashima Shinya, Nagata Hiroshi, Iwata Masahiro, Yokota Masaki, Moritomo Hiroyuki, Nakai Eiichi, Kuromitsu Sadao, Ohga Keiko, Takeuchi Makoto, NAGAI Shozo, January 8, 2004: WO/2004/002964 (69 worldwide citation)

(EN) A compound which is usable in the prevention of and/or treatments for respiratory diseases in which STAT 6 participates, especially asthma, chronic obstructive pulmonary diseases, etc. The compound is either a pyrimidine derivative having in the 2-position an arylamino or arylethylamino group o ...


2
Iwata Masahiro, Inotsume Fusako, Fujii Yuki, Tanaka Rie, Terao Arihito, Oshimi Ryu, Higuchi Satoshi: (en) Communication device, communication method, communication program, and storage medium enabling readout of data on computer(ja) 通信装置、通信方法、通信プログラムおよびコンピュータに読み取り可能な記憶媒体. Pioneer Corporation, Iwata Masahiro, Inotsume Fusako, Fujii Yuki, Tanaka Rie, Terao Arihito, Oshimi Ryu, Higuchi Satoshi, SAKAI Akinori, September 3, 2009: WO/2009/107245 (3 worldwide citation)

(EN) A communication system (100) comprises a communication device (110) and electronic apparatuses (121), (122). The communication device (110) includes a connection section (111) and a storage section (112). The connection section (111) makes connections with a plurality of electronic apparatuses ...


3
Noda Ichio, Iwata Masahiro, Sakamoto Shuichi, Koshiya Kazuo, Morita Takuma, Kohara Atsuyuki: Serine derivative. Yamanouchi Pharmaceutical, Noda Ichio, Iwata Masahiro, Sakamoto Shuichi, Koshiya Kazuo, Morita Takuma, Kohara Atsuyuki, NAGAI Shozo, November 10, 1994: WO/1994/025450

A serine derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, having an anti-PCP(phencyclidine) activity and being useful as a psychotropic, wherein X represents sulfur or oxygen; Y represents nitrogen or CH; R?1¿ and R?2¿ represent each independently hydrogen ...


4
Takayama Kazuhisa, Hisamichi Hiroyuki, Iwata Masahiro, Kubota Hideki, Aoki Motonori: Pyrido[2, 3-d] pyrimidine derivatives and medicinal compositions thereof. Yamanouchi Pharmaceutical, Takayama Kazuhisa, Hisamichi Hiroyuki, Iwata Masahiro, Kubota Hideki, Aoki Motonori, NAGAI Shozo, May 29, 1997: WO/1997/019078

Compounds represented by general formula (I) or pharmaceutically acceptable salts thereof which have the effect of inhibiting the activity of type IV phosphodiesterases and are usable as drugs, in particular, type IV phosphodiesterase inhibitors or preventives and remedies for diseases in associatio ...


5
Noda Ichio, Iwata Masahiro, Morita Takuma, Koshiya Kazuo, Sakamoto Syuichi, Kimura Takenori, Murakami Takeshi: Imidazolidinedione derivative. Yamanouchi Pharmaceutical, Noda Ichio, Iwata Masahiro, Morita Takuma, Koshiya Kazuo, Sakamoto Syuichi, Kimura Takenori, Murakami Takeshi, NAGAI Shozo, November 9, 1995: WO/1995/029910

An imidazolidinedione derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof, each having an anti-PCP(phencyclidine) effect and being useful as a psychotropic drug, etc. In said formula, n represents an integer of 2 to 9; A represents lower alkylene; ring B repre ...


6
Takayama Kazuhisa, Iwata Masahiro, Okamoto Yoshinori, Aoki Motonori, Niwa Akira, Isomura Yasuo: Novel naphthyridine derivative and medicinal composition thereof. Yamanouchi Pharmaceutical, Takayama Kazuhisa, Iwata Masahiro, Okamoto Yoshinori, Aoki Motonori, Niwa Akira, Isomura Yasuo, NAGAI Shozo, March 7, 1996: WO/1996/006843

A 1,8-naphthyridine derivative represented by general formula (I), and salt, hydrate and solvate thereof: the compound inhibits type IV phosphodiesterases and is useful as a preventive or remedy for respiratory diseases, inflammatory diseases, systemic or local joint diseases, proliferative diseases ...


7
Iwata Masahiro, Kawano Noriyuki, Takuwa Tomofumi, Shiraki Ryota, Kobayashi Miki, Takeuchi Makoto: Naphthyridine derivatives. Yamanouchi Pharmaceutical, Iwata Masahiro, Kawano Noriyuki, Takuwa Tomofumi, Shiraki Ryota, Kobayashi Miki, Takeuchi Makoto, NAGAI Shozo, May 3, 2001: WO/2001/030779

2-Oxo-1,2-dihydro-1,8-naphthyridine derivatives characterized by bearing a specific substituent, -X-R?6¿, at the 3-position and a cyclic substituent, R?5¿, at the 4-position; or salts thereof. The derivatives and the salts are useful as drugs, particularly preventive or therapeutic agents for respir ...


8
Iwata Masahiro, Kawano Noriyuki, Kaizawa Hiroyuki, Takuwa Tomofumi, Tsukamoto Issei, Seo Ryushi, Yahiro Kiyoshi, Kobayashi Miki, Takeuchi Makoto: Phenylpyridine carbonyl piperazine derivative. Yamanouchi Pharmaceutical, Iwata Masahiro, Kawano Noriyuki, Kaizawa Hiroyuki, Takuwa Tomofumi, Tsukamoto Issei, Seo Ryushi, Yahiro Kiyoshi, Kobayashi Miki, Takeuchi Makoto, NAGAI Shozo, December 27, 2002: WO/2002/102778

A compound represented by the following general formula, which has phosphodiesterase IV inhibitory activity; a use of the compound; and an intermediate therefor. (I) (In the formula, R1 and R2 each is hydrogen, halogeno, lower alkyl, lower alkoxy, etc.; R3 and R4 each is hydrogen, (su ...


9
Sakamoto Shuichi, Shishikura Jun Ichi, Iwata Masahiro, Okada Masamichi, Sasamata Masao: Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof. Yamanouchi Pharmaceutical, Sakamoto Shuichi, Shishikura Jun Ichi, Iwata Masahiro, Okada Masamichi, Sasamata Masao, NAGAI Shozo, November 24, 1994: WO/1994/026737

An imidazolylquinoxalinedione derivative, represented by general formula (I), useful as a glutamate receptor antagonist, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same as the active ingredient, wherein R?1¿ represents hydrogen or lower alkyl; R?2¿ re ...


10
Nakamura Koichi: Automobile ventilation device. Nakamura Koichi, Iwata Masahiro, March 11, 1997: JP1997-066730

PROBLEM TO BE SOLVED: To prevent a temperature increase in a car to a high level, by means of forced ventilation in the car which is caused, by a sun light incident on the inside of a tightly shut car through a glass window. SOLUTION: The inside temperature of an automobile is always monitored by a ...